Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14,LBP,and acute phase lipoproteins

Abstract

Sepsis-induced changes in human plasma decrease LPS association with monocytes by regulating dynamic interactions among LPS, monocytes, and plasma lipoproteins. In the physiological environment of undiluted human serum, we have found that: (i) LPS binds transiently to monocytes and is released into plasma lipoproteins; (ii) the release of LPS from monocytes is dependent upon lipoprotein acceptors and is enhanced by soluble CD14 (sCD14); and (iii) both lipoproteins and sCD14 can attenuate cytokine responses in monocytes that have already bound LPS. Whereas LPS binding protein (LBP) also inhibited LPS responses after LPS had bound to monocytes, this did not require extensive release of cell-bound LPS as was observed with sCD14. In the serum of septic patients, both free LPS and monocyte-bound LPS were usually transferred to lipoproteins at an accelerated rate. In spite of a sharp decline in HDL levels, HDL remained the dominant LPS acceptor in many severely septic patients, whereas in some cases LPS binding shifted largely to a non-HDL lipoprotein fraction that co-eluted according to size with very low-density lipoprotein (VLDL). Preliminary data suggest that these lipoproteins have a very low density, and they contain apolipoprotein E and higher than normal proportions of the total lipoprotein cholesterol, phospholipid, apolipoprotein B, and serum amyloid A. The data suggest that the VLDL fraction contains acute phase lipoproteins of significantly altered composition that can replace HDL as the dominant LPS acceptor during sepsis when HDL levels are low.

References

Kitchens RL , Thompson PA , O'Keefe GE , Munford RS Plasma constituents regulate LPS binding to, and release from, the monocyte cell surface. J Endotoxin Res 2000; 6: 477—482.

Wurfel MM , Kunitake ST , Lichenstein H. , Kane JP , Wright SD Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 1994; 180: 1025—1035.

Vesy CJ , Kitchens RL , Wolfbauer G. , Albers JJ , Munford RS LPS binding protein and phospholipid transfer protein release lipopolysaccharides from Gram-negative bacterial membranes. Infect Immun 1999; 68: 2410—2417.

Lamping N. , Dettmer R. , Schröder NW et al. LPS-binding protein protects mice from septic shock caused by LPS or Gram-negative bacteria. J Clin Invest 1998; 101: 2065—2071.

Zweigner J. , Gramm H-J. , Singer OC , Wegscheider K. , Schumann RR High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 2001; 98: 3800—3808.

Gegner JA , Ulevitch RJ , Tobias PS Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem 1995; 270: 5320—5326.

Schütt C. , Schilling T. , Kruger C. sCD14 prevents endotoxin inducible oxidative burst response of human monocytes . Allerg Immunol (Leipz) 1991; 37: 159—164.

Haziot A. , Rong G-W. , Bazil V. , Silver J. , Goyert SM Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-α production by cells in whole blood. J Immunol 1994; 152: 5868—5876.

Hailman E. , Vasselon T. , Kelley M. et al. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J Immunol 1996; 156: 4384—4390.

10.

Kitchens RL , Thompson PA , Viriyakosol S. , O'Keefe GE , Munford RS Plasma CD14 decreases monocyte responses to LPS by promoting the transfer of cell-bound LPS to plasma lipoproteins. J Clin Invest 2001; 108: 485—493.

11.

Khovidhunkit W. , Memon RA , Feingold KR , Grunfeld C. Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 2000 ; 181: S462—S472.

12.

Read TE , Grunfeld C. , Kumwenda ZL et al. Triglyceride-rich lipoproteins prevent septic death in rats . J Exp Med 1995; 182: 267—272.

13.

Harris HW , Gosnell JE , Kumwenda ZL The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity. J Endotoxin Res 2000; 6: 421—430.

14.

Kitchens RL , Wolfbauer G. , Albers JJ , Munford RS Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J Biol Chem 1999; 274: 34116—34122.

15.

Viriyakosol S. , Tobias PS , Kitchens RL , Kirkland TN MD-2 binds to bacterial lipopolysaccharide . J Biol Chem 2001; 276: 38044—38051.

16.

Parker TS , Levine DM , Chang Jcc , Laxer J. , Coffin CC , Rubin AL Reconstituted high-density lipoprotein neutralizes Gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun 1995; 63: 253—258.

17.

Levels Jhm , Abraham PR , Van den Ende A. , van Deventer Sjh. Distribution and kinetics of lipoprotein-bound endotoxin. Infect Immun 2001; 69: 2821—2828.

18.

Rensen Pcn , Van Oosten M. , Van de Bilt E. , Van Eck M. , Kuiper J. , Van Berkel Tjc. Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats in vivo. J Clin Invest 1997; 99: 2438—2445.